journal article·2023-03Open access

Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer

Cheng‐Che Chen, Yu‐Chen Fa, Yen‐Yu Kuo, Yi‐Chun Liu, Chih‐Yu Lin, Xin‐Hui Wang, Yu‐Huan Lu, Yu‐Han Chiang, Chia‐Min Yang, Li‐Chen Wu, Ja‐an Annie Ho

Advanced Science· Volume 10· Issue 7

Abstract

Abstract The characteristics of global prevalence and high recurrence of bladder cancer has led numerous efforts to develop new treatments. The spontaneous voiding and degradation of the chemodrug hamper the efficacy and effectiveness of intravesical chemotherapy following tumor resection. Herein, the externally thiolated hollow mesoporous silica nanoparticles (MSN‐SH(E)) is fabricated to serve as a platform for improved bladder intravesical therapy. Enhanced mucoadhesive effect of the thiolated nanovector is confirmed with porcine bladder. The permeation‐enhancing effect is also verified, and a fragmented distribution pattern of a tight junction protein, claudin‐4, indicates the opening of tight junction. Moreover, MSN‐SH(E)‐associated reprogramming of M2 macrophages to M1‐like phenotype is observed in vitro. The antitumor activity of the mitomycin C (MMC)‐loaded nanovector (MMC@MSN‐SH(E)) is more effective than that of MMC alone in both in vitro and in vivo. In addition, IHC staining is used to analyze IFN‐γ, TGF‐β1, and TNF‐α. These observations substantiated the significance of MMC@MSN‐SH(E) in promoting anticancer activity, holding the great potential for being used in intravesical therapy for non‐muscle invasive bladder cancer (NMIBC) due to its mucoadhesivity, enhanced permeation, immunomodulation, and prolonged and very efficient drug exposure.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bladder and Urothelial Cancer Treatments · Immune cells in cancer · Inflammatory Biomarkers in Disease Prognosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

BioAnalytical Chemistry and Nanobiomedicine Laboratory Department of Biochemical Science and Technology National Taiwan University 10617 Taipei Taiwan

Department of Urology Taichung Veterans General Hospital 40705 Taichung Taiwan

Department of Chemistry National Tsing Hua University 300044 Hsinchu Taiwan

Instrumentation Center National Taiwan University 10617 Taipei Taiwan

Department of Chemistry National Taiwan University 10617 Taipei Taiwan

Frontier Research Center on Fundamental and Applied Sciences of Matters National Tsing Hua University 300044 Hsinchu Taiwan

Department of Applied Chemistry National Chi Nan University Puli Nantou 54561 Taiwan

Center for Emerging Materials and Advance Devices National Taiwan University 10617 Taipei Taiwan

Center for Biotechnology National Taiwan University 10617 Taipei Taiwan

Funding

Taichung Veterans General Hospital

References (62)

Show source-provided references
1. 10.3322/caac.2159010.3322/caac.21590 ↗
2. 10.1097/MOU.000000000000007810.1097/MOU.0000000000000078 ↗
3. 10.5489/cuaj.332010.5489/cuaj.3320 ↗
4. 10.1016/j.juro.2016.06.04910.1016/j.juro.2016.06.049 ↗
5. Sylvester R. J. · Bladder Cancer · 2006 · 49 · 466
6. 10.1097/01.ju.0000125486.92260.b210.1097/01.ju.0000125486.92260.b2 ↗
7. 10.6004/jnccn.2020.001110.6004/jnccn.2020.0011 ↗
8. 10.6004/jnccn.2020.001110.6004/jnccn.2020.0011 ↗
9. Dalton J. T. · Cancer Res. · 1991 · 51 · 5144
10. 10.1007/s00345-011-0691-210.1007/s00345-011-0691-2 ↗
11. 10.1016/j.juro.2010.10.08110.1016/j.juro.2010.10.081 ↗
12. 10.1073/pnas.77.9.521610.1073/pnas.77.9.5216 ↗
13. Gao X. · Clin. Cancer Res. · 1998 · 4 · 139
14. 10.1016/j.euo.2018.08.03210.1016/j.euo.2018.08.032 ↗
15. 10.1016/j.purol.2019.11.00110.1016/j.purol.2019.11.001 ↗
16. 10.1177/175628721876206410.1177/1756287218762064 ↗
17. 10.1016/j.ejpb.2015.11.00310.1016/j.ejpb.2015.11.003 ↗
18. 10.1016/S0939-6411(03)00061-410.1016/S0939-6411(03)00061-4 ↗
19. 10.1023/A:101883020417010.1023/A:1018830204170 ↗
20. 10.1023/A:101534582709110.1023/A:1015345827091 ↗
21. 10.1016/j.ejpb.2019.01.02110.1016/j.ejpb.2019.01.021 ↗
22. 10.1021/acsami.9b2133510.1021/acsami.9b21335 ↗
23. 10.1517/17425247.2011.57206910.1517/17425247.2011.572069 ↗
24. 10.2217/nnm.11.16610.2217/nnm.11.166 ↗
25. 10.1002/adma.20110476310.1002/adma.201104763 ↗
26. 10.1080/17425247.2019.157580610.1080/17425247.2019.1575806 ↗
27. 10.1136/jitc-2021-00250810.1136/jitc-2021-002508 ↗
28. 10.7150/ntno.3005210.7150/ntno.30052 ↗
29. 10.1007/s12274-014-0503-210.1007/s12274-014-0503-2 ↗
30. 10.1016/j.jcis.2019.09.11410.1016/j.jcis.2019.09.114 ↗
31. 10.1186/s12951-021-00786-810.1186/s12951-021-00786-8 ↗
32. 10.1021/ja01269a02310.1021/ja01269a023 ↗
33. 10.1021/bi00377a00510.1021/bi00377a005 ↗
34. 10.1016/S1054-3589(08)61035-210.1016/S1054-3589(08)61035-2 ↗
35. 10.1023/A:101883020417010.1023/A:1018830204170 ↗
36. 10.1371/journal.pone.009274210.1371/journal.pone.0092742 ↗
37. 10.1021/acs.biomac.8b0183010.1021/acs.biomac.8b01830 ↗
38. 10.1021/ja00417a02010.1021/ja00417a020 ↗
39. 10.1021/bi00434a06210.1021/bi00434a062 ↗
40. 10.1016/j.jconrel.2003.05.00110.1016/j.jconrel.2003.05.001 ↗
41. 10.1016/j.ejpb.2018.10.01410.1016/j.ejpb.2018.10.014 ↗
42. 10.3390/ijms1802033610.3390/ijms18020336 ↗
43. 10.1073/pnas.040098310110.1073/pnas.0400983101 ↗
44. 10.1016/j.critrevonc.2007.07.00410.1016/j.critrevonc.2007.07.004 ↗
45. 10.1038/s41591-018-0014-x10.1038/s41591-018-0014-x ↗
46. 10.1016/j.toxlet.2008.10.01210.1016/j.toxlet.2008.10.012 ↗
47. 10.1038/nmat244210.1038/nmat2442 ↗
48. 10.1002/smll.20090115810.1002/smll.200901158 ↗
49. 10.1038/s41577-019-0127-610.1038/s41577-019-0127-6 ↗
50. 10.1002/adhm.20150101310.1002/adhm.201501013 ↗
51. 10.1073/pnas.191394011710.1073/pnas.1913940117 ↗
52. 10.1016/S0092-8674(00)00121-510.1016/S0092-8674(00)00121-5 ↗
53. 10.18632/oncotarget.965110.18632/oncotarget.9651 ↗
54. 10.1093/abbs/gmx12710.1093/abbs/gmx127 ↗
55. 10.1080/21645515.2017.132710710.1080/21645515.2017.1327107 ↗
56. 10.1016/j.urolonc.2010.12.00110.1016/j.urolonc.2010.12.001 ↗
57. 10.1038/nprot.2013.09510.1038/nprot.2013.095 ↗
58. 10.1080/10717544.2017.141345010.1080/10717544.2017.1413450 ↗
59. 10.1038/nprot.2007.30310.1038/nprot.2007.303 ↗
60. 10.4161/cbt.9.12.1163810.4161/cbt.9.12.11638 ↗
61. 10.1111/j.1464-410X.2009.08577.x10.1111/j.1464-410X.2009.08577.x ↗
62. 10.1007/978-1-60761-849-2_510.1007/978-1-60761-849-2_5 ↗